Table 1 Patient characteristics.

From: Tumor localization by Prostate Imaging and Reporting and Data System (PI-RADS) version 2.1 predicts prognosis of prostate cancer after radical prostatectomy

Characteristics

 

Total patients

299

Median age at surgery (range), y

67 (46–77)

Median PSA (range), ng/mL

7.6 (2.3–87.16)

PI-RADS v2.0 score, n (%)

 1–2/3/4/5

66 (22.1%)/25 (8.4%)/138 (46.2%)/70 (23.4%)

PI-RADS v2.1 score, n (%)

 1–2/3/4/5

35 (11.7%)/56 (18.7%)/138 (46.2%)/70 (23.4%)

Radiological location (TZ/PZ)

107/192

Surgical approach n (%)

 Open/laparoscopic/robot-assisted

33 (11.0%)/76 (25.4%)/190 (63.5%)

 Lymph node dissection, n (%)

234 (78.3%)

Pathological Grade Group, n (%)

 1/2/3/4/5

23 (7.7%)/123 (41.1%)/93 (31.1%)/24 (8.0%)/35 (11.7%)

Undiagnosed

1 (0.3%)

Extraprostatic extension (EPE1), n (%)

71 (23.7%)

Resection margin (RM+), n (%)

89 (29.8%)

Seminal vesicle invasion (SV+), n (%)

28 (9.4%)

Lymph node metastasis (N1), n (%)

4 (1.3%)

Median observation period (months)

49.8

Biochemical failure, n (%)

48 (16.1%)

  1. PSA prostate-specific antigen, PI-RADS Prostate Reporting and Imaging and Data System, TZ transition zone, PZ peripheral zone.